The Sleep Medicine and Research Foundation was created to fund the work and collaborations of Dr. Christian Guilleminault for the purposes of advancing sleep health worldwide. Dr. Guilleminault, MD,DM,DBiol, is a Professor in the Division of Sleep Medicine of the Stanford University Medical School. His career has been dedicated to answer the questions ‘Can we recognize the risks associated with development of abnormal breathing during sleep very early on, and sufficiently early to eliminate these risks factors by appropriate treatments? And can we prevent adult obstructive sleep apnea (OSA)?’ It is his goal to create a Multidisciplinary Treatment Program to understand the risk factors behind the development of abnormal breathing during sleep, develop tools that easily and early recognize children at risk, create new treatments avenues based on the findings, and test these new treatment approaches. Dissemination of findings and training specialists from any part of the world with creation of other multi-disciplinary efforts is another of Dr. Guilleminault’s goals.
Dr Guilleminault opened the first “center for sleep medicine” in Paris, at La Salepetriere University Hospital. He was recruited by Dr. William C. Dement to develop a sleep medicine center at Stanford, and he joined Stanford University Medical School in 1972. He has since been involved continuously in all aspects of sleep medicine, having published over 650 peer-reviewed articles and edited 8 books. A very brief highlight of his contributions:
- First described obstructive sleep apnea in children (1976),and the very negative consequences of this syndrome not only on the cardio-vascular system (1978), but also on learning, attention and school difficulties (1981)
- “Near-miss Sudden-infant death” infants may have their presentation due to abnormal breathing during sleep (1979), and may be related to abnormal oral facial growth also present in other family members (1986).
- Children with heavy snoring during sleep presented similar health problems as obstructive sleep apneic children (1982) and a technique for early recognition was emphasized. Early Application of nasal CPAP to treat children (1986). He recognized the problems associated with this treatment approach and has advocated for better diagnostic and treatment approaches for these children that represent between 7 and 12% of the general population with variable risks depending on ethnicity.
- The presence of familial aggregates of obstructive sleep apnea was further studied (1995), with a focus to recognize “at risk” children.
- Some children appear more at risk of the syndrome such as early premature infants (2013).
- Adjunctive orthodontics (2004) and myofunctional therapy (2013) as treatment approaches may allow better long term outcomes.
The Sleep Medicine and Research Foundation is a 501c3 organization, tax ID 47-3830022.
To donate, please see our donation information in the sidebar on any page.